tert-butyl N-(2-hydroxyethyl)carbamate → HCID 19596518, compound
Reaction equation
[OH:1][C:2]1[C:6]([CH:7]2[CH2:11][CH2:10][CH:9]=[CH:8]2)=[C:5]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)[O:4][N:3]=1.[C:18]([O:22][C:23]([NH:25][CH2:26][CH2:27]O)=[O:24])([CH3:21])([CH3:20])[CH3:19]>>[C:18]([O:22][C:23]([NH:25][CH2:26][CH2:27][O:1][C:2]1[C:6]([CH:7]2[CH2:11][CH2:10][CH:9]=[CH:8]2)=[C:5]([C:12]2[CH:13]=[CH:14][CH:15]=[CH:16][CH:17]=2)[O:4][N:3]=1)=[O:24])([CH3:21])([CH3:20])[CH3:19]Participants
3
Procedure
3-Hydroxy-4-(2-cyclopentenyl)-5-phenylisoxazole (227 mg) and 2-(N-tert-butoxycarbonylamino)ethanol (193 mg) were subjected to reaction and post-treatment in a similar manner to that described in Example 1(a) to obtain the title compound (295 mg, 80%) as colorless crystals.
Sources & evidence
- ORD record
- ord-c53ba3d925954ebf8c29f9ee39e5cdfb
- Source dataset
- uspto-grants-1999_12
- Patent number
- US06005116
Reaction notes
Loading…